180 related articles for article (PubMed ID: 25546392)
21. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.
Hussain A; Samad A; Singh SK; Ahsan MN; Faruk A; Ahmed FJ
Drug Dev Ind Pharm; 2015 May; 41(5):780-90. PubMed ID: 24654936
[TBL] [Abstract][Full Text] [Related]
22. Microemulsion based gel for topical dermal delivery of pseudolaric acid B: In vitro and in vivo evaluation.
Wan T; Xu T; Pan J; Qin M; Pan W; Zhang G; Wu Z; Wu C; Xu Y
Int J Pharm; 2015 Sep; 493(1-2):111-20. PubMed ID: 26216411
[TBL] [Abstract][Full Text] [Related]
23. Formulation characterization of lecithin organogel as topical drug delivery system for psoriasis: In-vitro permeation and preclinical evaluation.
Bule P; Kadkanje P; Kshirsagar R; Puppala ER; Naidu VGM; Chella N
Drug Dev Res; 2024 May; 85(3):e22191. PubMed ID: 38685610
[TBL] [Abstract][Full Text] [Related]
24. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
25. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways.
Lapteva M; Santer V; Mondon K; Patmanidis I; Chiriano G; Scapozza L; Gurny R; Möller M; Kalia YN
J Control Release; 2014 Dec; 196():9-18. PubMed ID: 25278258
[TBL] [Abstract][Full Text] [Related]
26. Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach.
Tiwari S; Dwivedi H; Kymonil KM; Saraf SA
Drug Deliv Transl Res; 2015 Jun; 5(3):219-30. PubMed ID: 25787730
[TBL] [Abstract][Full Text] [Related]
27. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities.
Wan T; Pan W; Long Y; Yu K; Liu S; Ruan W; Pan J; Qin M; Wu C; Xu Y
Int J Nanomedicine; 2017; 12():1485-1497. PubMed ID: 28260894
[TBL] [Abstract][Full Text] [Related]
28. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
29. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
30. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
31. Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules.
Lee WR; Shen SC; Al-Suwayeh SA; Yang HH; Yuan CY; Fang JY
J Control Release; 2011 Aug; 153(3):240-8. PubMed ID: 21435360
[TBL] [Abstract][Full Text] [Related]
32. Nanocarrier-based topical drug delivery for an antifungal drug.
Hussain A; Samad A; Nazish I; Ahmed FJ
Drug Dev Ind Pharm; 2014 Apr; 40(4):527-41. PubMed ID: 23627443
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W
J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308
[TBL] [Abstract][Full Text] [Related]
34. Development of aceclofenac nanovesicular system using biomaterial for transdermal delivery: physical characterization, ex vivo, in vivo, and anti-inflammatory studies.
Gaur PK; Purohit S; Mishra S
J Biomater Sci Polym Ed; 2013; 24(18):2126-41. PubMed ID: 23944964
[TBL] [Abstract][Full Text] [Related]
35. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
Nagle A; Goyal AK; Kesarla R; Murthy RR
J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
[TBL] [Abstract][Full Text] [Related]
36. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
Yang M; Gu Y; Yang D; Tang X; Liu J
J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
[TBL] [Abstract][Full Text] [Related]
37. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
38. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
[TBL] [Abstract][Full Text] [Related]
39. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Katara R; Majumdar DK
Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
[TBL] [Abstract][Full Text] [Related]
40. Biocompatible Nanoemulsions for Improved Aceclofenac Skin Delivery: Formulation Approach Using Combined Mixture-Process Experimental Design.
Isailović T; Ðorđević S; Marković B; Ranđelović D; Cekić N; Lukić M; Pantelić I; Daniels R; Savić S
J Pharm Sci; 2016 Jan; 105(1):308-23. PubMed ID: 26539935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]